SCHEMBL6313853

SCHEMBL6313853

Cn1c(=O)c2nc(C=O)c(NCCO)nc2n(C)c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.46
HTT P42858 3/20 0.46
PCSK9 Q8NBP7 10/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MAPK1 P28482 1/20 0.40
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 4/20 0.40
JAK2 O60674 1/20 0.40
HPGD P15428 1/20 0.40
PAX8 Q06710 1/20 0.40
CYP2C19 P33261 1/20 0.39
ATM Q13315 1/20 0.38
POLB P06746 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CASP1 P29466 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6323060 0.77 ALDH1A1 (0.42) LMNAHTTMEN1KMT2AMAPK1
SCHEMBL6324023 0.75 ALDH1A1 (0.40) LMNAHTTMEN1KMT2ASMN1; SMN2
SCHEMBL6321651 0.75 ALDH1A1 (0.47) LMNAHTTMEN1KMT2AMAPK1
SCHEMBL6316016 0.72 ALDH1A1 (0.47) LMNAHTTMEN1KMT2AMAPK1
SCHEMBL2182670 0.69 CYP2C19 (0.42) LMNAHTTPCSK9MEN1KMT2A
SCHEMBL2182521 0.68 LMNA (0.40) LMNAHTTPCSK9MEN1KMT2A
SCHEMBL26312966 0.68 ALDH1A1 (0.66) LMNAHTTMEN1KMT2AALDH1A1
SCHEMBL28144273 0.67 CYP2C19 (0.82) LMNAHTTPCSK9MEN1KMT2A
SCHEMBL2179999 0.67 LMNA (0.38) LMNAHTTPCSK9MEN1KMT2A
SCHEMBL11085426 0.67 KDM4E (0.38) HTTMEN1KMT2ASMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6946465-B2 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2005-09-20 US claimed
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2003-12-25 US claimed
US-6946465-B2 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2005-09-20 US disclosed
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2003-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives TPMT, FKBP5, RRP15 LMNA 3699/4885HTT 1845/4885PCSK9 4288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.